Derby & Company Inc. acquired a new stake in Stryker Co. (NYSE:SYK) during the fourth quarter, HoldingsChannel.com reports. The institutional investor acquired 6,600 shares of the medical technology company’s stock, valued at approximately $1,022,000. Stryker makes up about 0.7% of Derby & Company Inc.’s holdings, making the stock its 16th biggest position.
A number of other institutional investors and hedge funds have also recently made changes to their positions in the business. Jensen Investment Management Inc. boosted its position in Stryker by 0.3% in the 4th quarter. Jensen Investment Management Inc. now owns 2,478,958 shares of the medical technology company’s stock valued at $383,842,000 after buying an additional 6,482 shares during the last quarter. Legal & General Group Plc boosted its position in Stryker by 2.8% in the 3rd quarter. Legal & General Group Plc now owns 1,805,572 shares of the medical technology company’s stock valued at $256,393,000 after buying an additional 49,143 shares during the last quarter. Wells Fargo & Company MN boosted its position in Stryker by 4.8% in the 3rd quarter. Wells Fargo & Company MN now owns 1,742,959 shares of the medical technology company’s stock valued at $247,536,000 after buying an additional 79,551 shares during the last quarter. Swiss National Bank boosted its position in Stryker by 1.0% in the 3rd quarter. Swiss National Bank now owns 1,711,871 shares of the medical technology company’s stock valued at $243,120,000 after buying an additional 17,300 shares during the last quarter. Finally, Pictet Asset Management Ltd. boosted its position in Stryker by 25.4% in the 3rd quarter. Pictet Asset Management Ltd. now owns 1,286,239 shares of the medical technology company’s stock valued at $182,672,000 after buying an additional 260,502 shares during the last quarter. Hedge funds and other institutional investors own 74.49% of the company’s stock.
In other Stryker news, insider Graham A. Mclean sold 2,984 shares of Stryker stock in a transaction dated Monday, February 5th. The stock was sold at an average price of $160.53, for a total value of $479,021.52. Following the sale, the insider now owns 9,100 shares of the company’s stock, valued at approximately $1,460,823. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Also, VP William E. Berry, Jr. sold 1,306 shares of Stryker stock in a transaction dated Thursday, February 1st. The shares were sold at an average price of $164.42, for a total value of $214,732.52. The disclosure for this sale can be found here. Insiders have sold a total of 16,840 shares of company stock worth $2,749,989 in the last ninety days. 7.40% of the stock is currently owned by company insiders.
Shares of Stryker Co. (NYSE SYK) opened at $165.77 on Tuesday. The company has a market capitalization of $60,579.61, a price-to-earnings ratio of 61.85, a P/E/G ratio of 2.32 and a beta of 0.70. Stryker Co. has a 12 month low of $127.19 and a 12 month high of $170.00. The company has a debt-to-equity ratio of 0.66, a quick ratio of 1.59 and a current ratio of 2.29.
Stryker (NYSE:SYK) last issued its quarterly earnings data on Tuesday, January 30th. The medical technology company reported $1.96 EPS for the quarter, topping the Thomson Reuters’ consensus estimate of $1.95 by $0.01. The business had revenue of $3.47 billion for the quarter, compared to the consensus estimate of $3.42 billion. Stryker had a return on equity of 24.56% and a net margin of 8.20%. The firm’s revenue was up 9.9% compared to the same quarter last year. During the same quarter last year, the business posted $1.78 EPS. analysts expect that Stryker Co. will post 7.12 earnings per share for the current fiscal year.
The firm also recently disclosed a quarterly dividend, which will be paid on Monday, April 30th. Investors of record on Thursday, March 29th will be paid a dividend of $0.47 per share. This represents a $1.88 annualized dividend and a yield of 1.13%. The ex-dividend date is Wednesday, March 28th. Stryker’s payout ratio is presently 70.15%.
WARNING: “Derby & Company Inc. Acquires Shares of 6,600 Stryker Co. (SYK)” was posted by Ticker Report and is the property of of Ticker Report. If you are accessing this report on another publication, it was illegally stolen and republished in violation of United States & international copyright law. The correct version of this report can be accessed at https://www.tickerreport.com/banking-finance/3226081/derby-company-inc-acquires-shares-of-6600-stryker-co-syk.html.
Stryker Company Profile
Stryker Corporation is a medical technology company. The Company offers a range of medical technologies, including orthopedic, medical and surgical, and neurotechnology and spine products. The Company’s segments include Orthopaedics; MedSurg; Neurotechnology and Spine, and Corporate and Other. The Orthopaedics segment includes reconstructive (hip and knee) and trauma implant systems and other related products.
Want to see what other hedge funds are holding SYK? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Stryker Co. (NYSE:SYK).
Receive News & Ratings for Stryker Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Stryker and related companies with MarketBeat.com's FREE daily email newsletter.